Metoclopramide for Lactation Enhancement

Guideline-Based Recommendations

The American Academy of Pediatrics and American College of Obstetricians and Gynecologists identify metoclopramide as a primary medication used to induce lactation, with metoclopramide being FDA-approved, and it is explicitly compatible with use in lactating women 1
The American Academy of Pediatrics and American College of Obstetricians and Gynecologists recommend metoclopramide as a galactagogue that may increase milk supply, with metoclopramide being FDA-approved (unlike domperidone in the United States) 1

The American College of Obstetricians and Gynecologists suggests optimizing non-pharmacologic interventions, such as frequent feeding/pumping, proper latch, adequate maternal hydration and nutrition, before considering metoclopramide 1
The American College of Obstetricians and Gynecologists recommends excluding medical causes of low supply, such as retained placental fragments, thyroid dysfunction, insufficient glandular tissue, before prescribing metoclopramide 1

Domperidone and metoclopramide are the primary medications used to induce lactation, with domperidone being more commonly utilized despite not being FDA-approved for this indication in the United States, according to the American College of Obstetricians and Gynecologists 2, 3
Metoclopramide is also used as a galactagogue and may increase milk supply, and is compatible with use in lactating women, as recommended by the American Academy of Pediatrics 2, 3
Ensure access to breast pump if any delay in infant feeding occurs, as domperidone may increase supply before infant can effectively remove milk, as suggested by the World Health Organization 2, 3

The American Academy of Family Physicians recommends a maximum daily dose of 30 mg per day (10 mg three times daily) for breastfeeding women 4

The American College of Physicians notes that metoclopramide may increase milk supply by raising maternal serum prolactin levels, and it is compatible with breastfeeding 5
The American Academy of Family Physicians suggests that mothers taking metoclopramide should have access to a breast pump in case of delayed feeding to manage increased milk production 5

The American Academy of Family Physicians recommends that metoclopramide can be given orally or intravenously (10 mg IV) for breastfeeding women 4, 6
The American Society of Anesthesiologists notes that there is no need to interrupt breastfeeding or pump and discard milk when taking metoclopramide at recommended doses 5

Women taking metoclopramide should have access to a breast pump if there is any delay in feeding, as the medication may increase milk supply before the infant can effectively remove it, according to Anaesthesia 7
The medication has low oral bioavailability (30%) but achieves therapeutic effects through its central dopamine antagonism, as reported in Anaesthesia 8

The American College of Obstetricians and Gynecologists recommends optimizing non-pharmacologic interventions first, such as frequent feeding/pumping, proper latch technique, adequate maternal hydration and nutrition, before considering metoclopramide, although the specific recommendation is not directly cited here, the general principle is supported by various guidelines, including those from the American Academy of Pediatrics and American College of Obstetricians and Gynecologists 7